Adaptive Biotechnologies (ADPT) Misses Q4 EPS by 18c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.28 -1.18%
EPS Growth %: -266.7%
Financial Fact:
Revenues: 24.65M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -266.7%
Financial Fact:
Revenues: 24.65M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.48), $0.18 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.78 million versus the consensus estimate of $48.45 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
